Medical products developer B. Braun Medical has entered into an agreement to purchase a bloodlines business from medical technology company NxStage Medical.

Operated under the Medisystems brand, the bloodlines business contains a portfolio of blood tubing solutions intended for the elimination of blood-air interfaces. The blood tubing products are called Streamline Long, Streamline Express and Streamline.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

The business’s portfolio also contains a tubing product called Reverso, which allows easy blood flow reversal during treatment.

“The deal is subject to Federal Trade Commission approval and contingent upon the closing of the pending merger between NxStage Medical and a unit of Fresenius Medical.”

Braun expects the acquisition, which will expand the company’s dialysis product range, to facilitate better promotion of Streamline.

Braun Medical vice-president Sam Amory said: “We are pleased to add the Streamline bloodline to our dialysis product portfolio.

“Although we have been selling Streamline for many years, this acquisition will allow us to more broadly promote Streamline’s benefits as part of our transformative system of products, which includes the Dialog haemodialysis machine and the Diacap PRO dialyser.”

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

The deal is subject to Federal Trade Commission approval and contingent upon the closing of the pending merger between NxStage Medical and a unit of Fresenius Medical.

Braun anticipates completing its acquisition of the bloodlines business this year.

The company develops, manufactures and markets new medical products and services for the healthcare market. It primarily focuses on renal therapies, infusion therapy and pain management.

It aims to eliminate preventable treatment errors and improve patient, clinician and environmental safety.

With more than 61,000 employees across 64 countries, B. Braun’s sister companies include B. Braun Interventional Systems, Aesculap and CAPS.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
Awarded for Innovation in Remote Hearing Diagnostics , hearX’s Self Test Kit (STK) delivers clinically validated audiometry via smart devices, enabling remote, scalable hearing assessments in homes, clinics and retail. Learn how hearX is redefining hearing care delivery and reducing costs for providers globally.

Discover the Impact